Neuroendocrine cancer medicine

This article provides an overview of the current state of the imaging modalities used for primary tumor visualization, staging and follow-up. Detection of NETs and patient monitoring relies mainly on anatomical imaging such as computed tomography CTmagnetic resonance imaging MRIand ultrasonography US under certain conditions.

Molecular imaging techniques in combination with CT or MRI hybrid imaging greatly benefit patient management, including neuroendocrine cancer medicine localization of occult tumors and better staging. Diagnosis of patients with NETs is a complex process and, it is unlikely that any single diagnostic modality to be effective. Thus, NET diagnosis is a process utilizing a variety of methods including blood, urine and tumor tissue samples in combination with anatomical or hybrid imaging for localization, delineation and staging of the disease.

• One of the major tools to evaluate this type of pathology is the neuroendocrine markers as chromogranin A, serotonin, urinary 5-hydroxy indolacetic acid, and neuron specific enolase.
• Benign respiratory papillomatosis

Diagnostic approach to patients with NETs should focus on including hybrid imaging methods, which might play an important role in the future. Neuroendocrine tumor disease: an evolving landscape.

• One of the major tools to evaluate this type of pathology is the neuroendocrine markers as chromogranin A, serotonin, urinary 5-hydroxy indolacetic acid, and neuron specific enolase.
• Papiloma krema za muskarce

Endocr Relat Cancer ; 19 5 : R The epidemiology of gastroen-teropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am ; 40 1 Anghel L, Arsenescu-Georgescu C.

What is hiding the diabetes in the new left bundle branch block patietiens? Acta Endo, Bucureşti, ; 10 3 : Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.

Endocrine Practice. Metastatic carcinoid tumor-atypical presentation. Iasi ; 4 : Imaging in neuroendocrine tumors: an update for the clinician. International Journal ; 2 2 : Martucci VL, Pacak K.

Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer ; 38 1 : J Nucl Med ; Mansi L, Cuccurullo V.

Diagnostic imaging in neuroendocrine tumors. J Nucl Med ; neuroendocrine cancer medicine 10 : Nuclear medicine techniques for the neuroendocrine cancer medicine and treatment of neuroendocrine tumours.

Endocrine-related cancer ; neuroendocrine cancer medicine S1 : S Clinical and Translational Imaging ; 1 2 : Monitoring of recurrence in patients radically operated.

Iasi Iaşi ; 2 : Endocrine ;